ADTX News and Press, ADiTx Therapeutics Inc. From 04/01/21

TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore™ for COVID-19 through its mobile testing centres. Aditx Therapeutic...

Aditx Therapeutics ([[ADTX]] -3.7%) announced the upcoming launch of the first-in-human clinical trials of its therapeutic program for psoriasis.Its AditxtReprogramming therapeutics division will initiate Phase 1/2 trials Q4 2020 to evaluate the safety and efficacy of nucleic acid-b...

Aditxt to Initiate First-In-Human Clinical Trials with its Therapeutics Programs in Psoriasis by Year-End Aditxt Engages Regulatory Consultant in Preparation for Submission of an IND Application to the Regulatory Agency in Germany PR Newswire MOUNTAIN VIEW, Calif. ...

Detroit, Michigan--(Newsfile Corp. - March 22, 2021) - Aditxt (NASDAQ: ADTX) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our shareholders and all interested parties to explore biotech small cap investment opportunities throug...

Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...

Mountain View, CA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Eazy Testing Inc....

CollPlant Biotechnologies CLGN -28% on stock offering.iFresh (IFMK) -26%.Amicus Therapeutics FOLD -25% after PROPEL data in Pompe disease; Cantor cuts to Neutral.Limelight Networks LLNW -23% on Q4 earnings.Applied DNA Sciences APDN -19%. on FQ1 earnings.Diff...

Gainers: ESSA Pharma (EPIX) +47%. Ayala Pharmaceuticals (AYLA) +45%. GenMark Diagnostics (GNMK) +27%. ADiTx Therapeutics (ADTX) +27%. Celsion (CLSN) +26%.Losers: Tilray (TLRY) -39%. Anchiano Therapeutics (ANCN) -35%. Zynerba Pharmaceuticals (ZYNE) -28%. Pulmatrix (PULM) -26%. Aphria (APHA) -2...

Can These 4 Penny Stocks Continue to Make Headway? So far, February has been kind to a variety of penny stocks . While this month has been quite volatile for the entire stock market, the sentiment seems to be quite bullish overall. Right now, several pieces of news could impact the ...

Dr. Tyan Will Lead and Advance Organ Transplantation Therapeutic Program Mountain View, CA, Jan. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company developing bi...